Biopharmaceutical Engineering
The MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry.
| Award Name | Degree - Masters (Level 9 NFQ) |
|---|---|
| NFQ Classification | Major |
| Awarding Body | National University of Ireland |
| NFQ Level | Level 9 NFQ |
| Award Name | NFQ Classification | Awarding Body | NFQ Level |
|---|---|---|---|
| Degree - Masters (Level 9 NFQ) | Major | National University of Ireland | Level 9 NFQ |
Duration
1 year full-time, 2 years part-time.
MODE OF DELIVERY: Face-to-Face
Entry Requirements
An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.
Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.
These are the minimum entry requirements – additional criteria may be requested for some programmes
Careers / Further progression
Career & Graduate Study Opportunity
Your career opportunities upon graduation from this programme are exemplary. Ireland is a world player in pharmaceutical and biopharmaceutical production.
The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.
Further information
Next Intake: 2024/2025 September.
MEngSc Biopharmaceutical Engineering (T070) Full Time
EU fee per year - € 9300
nonEU fee per year - € 29100
***Fees are subject to change
Please note that UCD offers a number of graduate scholarships for full-time, self-funding international students, holding an offer of a place on a UCD graduate degree programme. For further information please see www.ucd.ie/global/scholarships/
MEngSc Biopharmaceutical Engineering (T015) Part Time
nonEU Year 2 - € 13860 aa
EU Year 3 - € 2290 vb
nonEU Year 3 - € 6772 vb
EU Year 1 - € 7100
nonEU Year 1 - € 14550
EU Year 2 - € 6760 aa
aaSecond Year Fee applies to Students in 2nd Year in 2024 and who were a 1st Year Student on the programme in 2023/24
vbThird Year Fee applies to Students in 3rd Year in 2024 and who were a 1st Year Student on the programme in 2022/23
***Fees are subject to change
The following entry routes are available:
MEngSc Biopharmaceutical Engineering FT (T070)
Duration 1 Years Attend Full Time
Deadline Rolling*
* Courses will remain open until such time as all places have been filled, therefore early application is advised
The following entry routes are available:
The following entry routes are available:
MEngSc Biopharmaceutical Engineering PT (T015)
Duration 2 Years
Attend Part Time
Deadline Rolling*
* Courses will remain open until such time as all places have been filled, therefore early application is advised
Pharmaceutical and Biopharmaceutical manufacturing are key sectors in the Irish economy generating over 50 per cent of GDP. This sector has seen continued and sustained success with a number of high-profile investments in recent years providing excellent job opportunities for graduates. The programme and its academic faculty are closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing.
The MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. The aim of this programme is to offer an internationally recognised high-quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.
This programme has an excellent employment record. It equips graduates with an internationally recognised qualification and the knowledge and skills to obtain a high level professional career in the Biopharmaceutical, Pharmaceutical and related sectors.
Stage 1 - Core
Principles of Biopharmaceutical Engineering (FT)CHEN40020
Animal Cell Culture Technology (FT)CHEN40040
Bioprocessing LaboratoryCHEN40090
Facility Design and OperationCHEN40110
Biopharmaceutical Industry Regulation and ManagementCHEN40120
Biopharmaceutical Engineering ProjectCHEN40140
Downstream ProcessingCHEN40460
Bioprocess DesignCHEN40530
Bioanalytical Science for BiopharmaCHEN40630
Data Sci for Biopharm ManufactCHEN40770
Research Methodology FTCHEN40890
Stage 1 - Option
Bioprocess Scale-up and Technology TransferCHEN40130
Gene Ther & Vacc Tech & ProcCHEN40860
GMP Manufact Advan TherapeuticCHEN40870
Programme Outcomes
Apply their knowledge of biopharmaceutical production processes to design, equip and manage a biopharmaceutical production factility
Demonstrate an appreciation of the concept and practice of independent research in specialised topics in biopharmaceutical engineering
Demonstrate an integrated knowledge of GMP and the regulatory issues involved in biopharmaceutical production
Demonstrate an understanding and appreciation of the challenges involved in the downstream purification of biopharmaceuticals
Demonstrate an understanding of the fundamentals of process control when applied to growth of mammalian cells in bioreactors
Demonstrate an understanding of the scientific principles involved in the development of a biopharmaceutical production process
Demonstrate the ability to work as part of a design team for the development of a new production facility
Understand the engineering principles underlying the production of biopharmaceuticals
Contact Name: Katie O'Neill
Contact Number: +353 (0)1 716 1781